| Literature DB >> 29649123 |
Yang Cao1, Zheng Feei Ma2,3, Hongxia Zhang4, Yifan Jin5, Yihe Zhang6, Frank Hayford7.
Abstract
The human gut is densely populated with diverse microbial communities that are essential to health. Prebiotics and fiber have been shown to possess the ability to modulate the gut microbiota. One of the plants being considered as a potential source of prebiotic is yacon. Yacon is an underutilized plant consumed as a traditional root-based fruit in South America. Yacon mainly contains fructooligosaccharides (FOS) and inulin. Therefore, it has bifidogenic benefits for gut health, because FOS are not easily broken down by digestive enzymes. Bioactive chemical compounds and extracts isolated from yacon have been studied for their various nutrigenomic properties, including as a prebiotic for intestinal health and their antimicrobial and antioxidant effects. This article reviewed scientific studies regarding the bioactive chemical compounds and nutrigenomic properties of extracts and isolated compounds from yacon. These findings may help in further research to investigate yacon-based nutritional products. Yacon can be considered a potential prebiotic source and a novel functional food. However, more detailed epidemiological, animal, and human clinical studies, particularly mechanism-based and phytopharmacological studies, are lacking for the development of evidence-based functional food products.Entities:
Keywords: Smallanthus sonchifolius; fructooligosaccharides; prebiotic; underutilized; yacon
Year: 2018 PMID: 29649123 PMCID: PMC5920424 DOI: 10.3390/foods7040059
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Chemical composition of 1 kg fresh yacon root [13].
| Variables | Mean |
|---|---|
| Dry matter (g) | 115 |
| Total carbohydrates (g) | 106 |
| Fructans (g) | 62 |
| Total free sugars (g) | 26 |
| 3.5 | |
| 14 | |
| 8.5 | |
| Protein (g) | 3.7 |
| Fiber (g) | 3.6 |
| Fat (mg) | 244 |
| Calcium (mg) | 87 |
| Potassium (mg) | 2282 |
| Phosphorus (mg) | 240 |
An overview of major phytochemical compounds of yacon.
| Parts of Yacon | Compounds/Nutrients Identified | Test Methods | References |
|---|---|---|---|
| Roots/tubers | Fructooligosacharides (1-kestose, nystose, and 1-fructofuranosyl nystose) | Fermentation by | Hermann et al. (1997) [ |
| Tryptophan | 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) | Sousa et al. (2015) [ | |
| Chlorogenic acid | ABTS | Sousa et al. (2015) [ | |
| Caffeic acid | ABTS | Sousa et al. (2015) [ | |
| Ferulic acid | 1,1-diphenyl-2-picrylhydrazyl (DPPH) | Simonovska et al. (2003) [ | |
| Leaves | Chlorogenic acid | Decoction | Yan et al. (1999) [ |
| Caffeic acid | Decoction | Genta et al. (2009) [ | |
| Ferulic acid | DPPH and xanthine/XOD superoxide radical scavenging assays | Valentová et al. (2003) [ | |
| Myricetin | Ohmic-assisted decoction | Khajehei et al. (2017) [ | |
| Rutin | Decoction | De Andrade et al. (2014) [ | |
| Ohmic-assisted decoction | Khajehei et al. (2017) [ | ||
| Gallic acid | Decoction | De Andrade et al. (2014) [ | |
| Tryptophan | DPPH assay | Yan et al. (1999) [ | |
| Enhydrin | Decoction | Genta et al. (2009) [ | |
| Flower | Myricetin | Decoction | De Andrade et al. (2014) [ |
| Gallic acid | Decoction | De Andrade et al. (2014) [ |
An overview of major nutrigenomic properties of yacon.
| Pharmacological Effects | Models Used | Parts/Forms of Yacon Used | References |
|---|---|---|---|
| Hypoglycemia effect | Streptozotocin-induced diabetic rats | Leaf extract | Aybar et al. (2001) [ |
| Diabetic rats | Aqueous leaf extract | Simonovska et al. (2003) [ | |
| Streptozotocin-induced diabetic and nondiabetic rats | Leaf extract | Baroni et al. (2008) [ | |
| Streptozotocin-induced diabetic rats | Dried root extract | Satoh et al. (2013) [ | |
| Normoglycemic, transiently hyperglycemic, and diabetic rats | Leaf extract | Genta et al. (2009) [ | |
| Decoction and enhydrin-fed Wistar rats | Leaf extract | Barcellona et al. (2012) [ | |
| Humans | Freeze-dried powder | Scheid et al. (2014) [ | |
| Humans | Syrup | Genta et al. (2009) [ | |
| Hypolipidemic effect | Normal and streptozotocin-induced diabetic rats | Dried root flour | Genta et al. (2005) [ |
| Hypercholesterolemic male Wistar rats | Root extract | Oliveira et al. (2016) [ | |
| Mildly dyslipidemic premenopausal women | Genta et al. (2009) [ | ||
| Anti-inflammatory effects | Hypercholesterolemic rats | Root extract | Oliveira et al. (2016) [ |
| Adult male BALB/c mice | Leaf extract | Inoue et al. (1995) [ | |
| Antimicrobial effects | Leaf extract | Inoue et al. (1994) [ | |
| Leaf extract | Lin et al. (2003) [ | ||
| Gram-positive organisms ( | Leaf extract | Padla et al. (2012) [ |